These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21288486)

  • 1. Impact of pH on bacterial growth and activity of recent fluoroquinolones in pooled urine.
    Erdogan-Yildirim Z; Burian A; Manafi M; Zeitlinger M
    Res Microbiol; 2011 Apr; 162(3):249-52. PubMed ID: 21288486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine.
    Burian A; Erdogan Z; Jandrisits C; Zeitlinger M
    Pharmacology; 2012; 90(5-6):281-7. PubMed ID: 23037005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
    So W; Crandon JL; Nicolau DP
    J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein binding of fluoroquinolones affects antimicrobial activity.
    Zeitlinger M; Sauermann R; Fille M; Hausdorfer J; Leitner I; Müller M
    J Antimicrob Chemother; 2008 Mar; 61(3):561-7. PubMed ID: 18216178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A; Schubert S
    Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The concentrations of fluoroquinolones in prevention of Staphylococcus epidermidis from mutant in ocular surface].
    Sun ST; Chen ZJ; Xu J; Tian XL
    Zhonghua Yan Ke Za Zhi; 2006 Nov; 42(11):989-91. PubMed ID: 17386136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L; Schito AM; Schito GC; Marchese A
    Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
    Ramakrishnan R; Ramesh S; Bharathi MJ; Amuthan M; Viswanathan S
    Indian J Pathol Microbiol; 2010; 53(2):276-80. PubMed ID: 20551532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli.
    Pellet T; Gicquel-Bruneau M; Sanders P; Laurentie M
    Res Vet Sci; 2006 Jun; 80(3):324-35. PubMed ID: 16126240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency of in vitro resistance to fluoroquinolones among clinical isolates of Escherichia coli.
    Poiată A; Bădicuţ I; Grigore L; Buiuc D
    Roum Arch Microbiol Immunol; 2000; 59(1-2):63-9. PubMed ID: 11845477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of human urine on the in vitro activity and postantibiotic effect of ciprofloxacin against Escherichia coli.
    Zhanel GG; Karlowsky JA; Davidson RJ; Hoban DJ
    Chemotherapy; 1991; 37(3):218-23. PubMed ID: 1889309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity in urine: effect on leukocyte count and bacterial culture results.
    Abu Shaqra QM
    New Microbiol; 2001 Apr; 24(2):137-42. PubMed ID: 11346296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Suto S; Zagar Z
    Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of changes in pH, medium and inoculum size on the in vitro activity of different quinolone and fluoroquinolone antibiotics against urinary pathogens.
    Gesu GP; Eftimiadi C; Debbia E; Schito GC
    Drugs Exp Clin Res; 1987; 13(2):79-84. PubMed ID: 3556122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary bactericidal activity of single doses (250, 500, 750 and 1000 mg) of levofloxacin against fluoroquinolone-resistant strains of Escherichia coli.
    Stein GE; Schooley SL; Nicolau DP
    Int J Antimicrob Agents; 2008 Oct; 32(4):320-5. PubMed ID: 18715762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
    Tayfour M; Yuce A; Yulug N
    Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of glucose added urine on the in vitro antimicrobial activity of various antibiotics.
    Gönüllü N; Küçükbasmaci O; Büyükbaba-Boral O; Anğ-Küçüker M
    Indian J Med Res; 2008 Nov; 128(5):663-5. PubMed ID: 19179689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
    Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.